New pediatric interventional device for PAH wins ‘Shark Tank’ event at TCT 2023

Michael Walter | October 26, 2023 | Cardiovascular Business | Interventional Cardiology

HeartPoint Global Shark Tank Intellistent

Elena K. Amin, MBChB, a pediatric cardiologist with UCSF Health, poses with the winning device. Photo by Dave Fornell.

HeartPoint Global, a Florida-based healthcare technology company focused on improving patient access to high-quality technology, won the Shark Take Innovation Competition at TCT 2023 with its Intellistent multi-lumen stent system. The device, already patented in more than 20 countries, is designed to help cardiologists treat pulmonary arterial hypertension (PAH) in congenital heart disease patients by allowing for the adjustment of blood flow into the patient’s heart-lung system.

According to HeartPoint Global, the minimally invasive device was designed to deliver benefits comparable to what is typically seen with surgical treatment. It may also serve as a bridge to surgery for some cardiac patients.

“We are deeply honored to be bestowed with this prestigious award,” Seth Bogner, HeartPoint Global’s chairman and CEO, said in a prepared statement. “TCT stands as a pinnacle platform for highlighting innovation in cardiovascular medicine. Having our technology acknowledged by such a distinguished panel of judges is truly humbling. We are eager to forge ahead with HeartPoint Global's in-human trials and anticipate its substantial clinical impact in the future.”

Elena K. Amin, MBChB, a pediatric cardiologist with UCSF Health, presented her team’s data during the Shark Tank competition. Six finalists were selected to attend TCT 2023 and present their technology, and HeartPoint Global took home a $200,000 prize for winning the competition. A panel of physicians, investors and industry experts served as judges.

HeartPoint Global plans on using the technology behind the Intellistent to treat numerous other conditions in the future. Click here to read an analysis of the technology published in JACC: Basic to Translational Science, an American College of Cardiology journal.[1]

Late-breaking clinical trials at TCT 2023 could lead to FDA approvals for Abbott, Boston Scientific

PARTNER 3, Evolut and more: TAVR takes the spotlight in 4 late-breaking clinical trials at TCT 2023

Shockwave Medical introducing more efficient IVL catheter to US market at TCT 2023

Late-breaking clinical trials at TCT 2023

‘Massive leap forward’: 4D MRI helps diagnose prenatal congenital heart disease

Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."